Funding for this research was provided by:
Dr. August Wolff GmbH & Ko. KG Arzneimittel
Otto-von-Guericke-Universität Magdeburg
Article History
Received: 20 April 2020
Accepted: 12 May 2021
First Online: 2 June 2021
Declarations
:
: Not applicable
: Not applicable
: Christian Apfelbacher has received institutional funding from Dr. August Wolff GmbH & Co. KG Arzneimittel, and consultancy fees from Dr. August Wolff GmbH & Co. KG Arzneimittel and Sanofi Genzyme. He is a member of the executive committee of the Harmonising Outcome Measures for Eczema (HOME) initiative.